• AbbVie EPS for the quarter ending June 30, 2024 was $0.77, a 32.46% decline year-over-year.
• AbbVie 2023 annual EPS was $2.72, a 58.97% decline from 2022.
• AbbVie 2022 annual EPS was $6.63, a 2.79% increase from 2021.
• AbbVie 2021 annual EPS was $6.45, a 137.13% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.